Tag Archives: SARSCoV2

Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants, study finds

Researchers at La Jolla Institute for Immunology (LJI) have found that T cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-CoV-2 variants. Their new study, published online on July 1, 2021 in Cell Reports Medicine, shows that both CD4+ “helper” T… Read More »